Status:
UNKNOWN
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Center for Research Resources (NCRR)
Conditions:
Advanced Cancers
Eligibility:
All Genders
Brief Summary
Primary Objective The primary objective of this study is to establish a program for the molecular profiling of patients with advanced cancer, with the goals of (1) providing a comprehensive characteri...
Detailed Description
The prognosis of patients with advanced metastatic malignancies is poor, and their median survival, irrespective of diagnosis, is approximately 8.8 months (95% confidence interval, 7.4 to 10.9 months)...
Eligibility Criteria
Inclusion
- 1\) Any patient seen in the department of Investigational Cancer Therapeutics is eligible. Patients who have blood or tissue samples collected must be registered on the tissue bank protocol (LAB07-0817).
Exclusion
- N/A
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00851032
Start Date
February 1 2009
End Date
February 1 2021
Last Update
May 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030